-
Notifications
You must be signed in to change notification settings - Fork 0
/
Copy pathentities_train.csv
We can't make this file beautiful and searchable because it's too large.
13637 lines (13637 loc) · 800 KB
/
entities_train.csv
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
id abstract_id offset_start offset_finish type mention entity_ids
0 1353340 11 39 DiseaseOrPhenotypicFeature metachromatic leukodystrophy D007966
1 1353340 111 126 GeneOrGeneProduct arylsulfatase A 410
2 1353340 128 132 GeneOrGeneProduct ARSA 410
3 1353340 159 187 DiseaseOrPhenotypicFeature metachromatic leukodystrophy D007966
4 1353340 189 192 DiseaseOrPhenotypicFeature MLD D007966
5 1353340 210 220 SequenceVariant arginine84 rs74315458
6 1353340 264 277 GeneOrGeneProduct arylsulfatase 410
7 1353340 363 366 DiseaseOrPhenotypicFeature MLD D007966
8 1353340 372 395 SequenceVariant arginine84 to glutamine rs74315458
9 1353340 442 446 GeneOrGeneProduct ARSA 410
10 1353340 484 488 GeneOrGeneProduct ARSA 410
11 1353340 562 570 OrganismTaxon patients 9606
12 1353340 576 579 DiseaseOrPhenotypicFeature MLD D007966
13 1353340 655 659 GeneOrGeneProduct ARSA 410
14 1353340 712 715 DiseaseOrPhenotypicFeature MLD D007966
15 1671881 49 64 DiseaseOrPhenotypicFeature phenylketonuria D010661
16 1671881 66 91 DiseaseOrPhenotypicFeature Classical phenylketonuria D010661
17 1671881 98 125 DiseaseOrPhenotypicFeature autosomal recessive disease D030342
18 1671881 138 185 DiseaseOrPhenotypicFeature deficiency of hepatic phenylalanine hydroxylase OMIM:261600
19 1671881 187 190 GeneOrGeneProduct PAH 5053
20 1671881 272 275 GeneOrGeneProduct PAH 5053
21 1671881 362 376 SequenceVariant 272gly----stop rs62514952
22 1671881 381 394 SequenceVariant 273ser----phe rs62514953
23 1671881 606 609 DiseaseOrPhenotypicFeature PKU D010661
24 1671881 684 700 DiseaseOrPhenotypicFeature PAH deficiencies OMIM:261600
25 1848636 0 12 ChemicalEntity Debrisoquine D003647
26 1848636 52 67 GeneOrGeneProduct beta-2 receptor 154
27 1848636 88 98 ChemicalEntity metoprolol D008790
28 1848636 171 181 ChemicalEntity metoprolol D008790
29 1848636 214 226 ChemicalEntity debrisoquine D003647
30 1848636 227 236 ChemicalEntity sparteine D013034
31 1848636 390 409 GeneOrGeneProduct beta-1 adrenoceptor 153
32 1848636 442 452 ChemicalEntity metoprolol D008790
33 1848636 511 530 GeneOrGeneProduct beta-2 adrenoceptor 154
34 1848636 545 555 ChemicalEntity metoprolol D008790
35 1848636 603 613 ChemicalEntity metoprolol D008790
36 1848636 617 628 ChemicalEntity terbutaline D013726
37 1848636 637 648 DiseaseOrPhenotypicFeature hypokalemia D007008
38 1848636 732 742 ChemicalEntity metoprolol D008790
39 1848636 838 848 ChemicalEntity metoprolol D008790
40 1848636 944 955 ChemicalEntity terbutaline D013726
41 1848636 1059 1069 ChemicalEntity metoprolol D008790
42 1848636 1149 1160 ChemicalEntity terbutaline D013726
43 1848636 1227 1236 ChemicalEntity potassium D011188
44 1848636 1238 1249 ChemicalEntity terbutaline D013726
45 1848636 1251 1261 ChemicalEntity metoprolol D008790
46 1848636 1294 1317 ChemicalEntity alpha-hydroxymetoprolol C029504
47 1848636 1389 1399 ChemicalEntity metoprolol D008790
48 1848636 1409 1419 ChemicalEntity metoprolol D008790
49 1848636 1434 1445 ChemicalEntity terbutaline D013726
50 1848636 1512 1522 ChemicalEntity metoprolol D008790
51 1848636 1523 1546 ChemicalEntity alpha-hydroxymetoprolol C029504
52 1848636 1652 1662 ChemicalEntity metoprolol D008790
53 1848636 1691 1701 ChemicalEntity metoprolol D008790
54 2422478 11 20 ChemicalEntity serotonin D012701
55 2422478 31 34 OrganismTaxon rat 10116
56 2422478 59 70 DiseaseOrPhenotypicFeature hypotensive D007022
57 2422478 81 91 ChemicalEntity methyldopa D008750
58 2422478 167 177 ChemicalEntity methyldopa D008750
59 2422478 217 226 ChemicalEntity serotonin D012701
60 2422478 260 271 DiseaseOrPhenotypicFeature hypotensive D007022
61 2422478 432 441 ChemicalEntity serotonin D012701
62 2422478 517 529 DiseaseOrPhenotypicFeature hypertensive D006973
63 2422478 531 537 DiseaseOrPhenotypicFeature stroke D020521
64 2422478 544 548 OrganismTaxon rats 10116
65 2422478 568 578 ChemicalEntity methyldopa D008750
66 2422478 611 620 ChemicalEntity serotonin D012701
67 2422478 671 682 DiseaseOrPhenotypicFeature hypotension D007022
68 2422478 769 778 ChemicalEntity serotonin D012701
69 2422478 790 813 ChemicalEntity 5,7-dihydroxytryptamine D015116
70 2422478 815 822 ChemicalEntity 5,7-DHT D015116
71 2422478 894 901 ChemicalEntity 5,7-DHT D015116
72 2422478 956 965 ChemicalEntity serotonin D012701
73 2422478 1017 1028 DiseaseOrPhenotypicFeature hypotension D007022
74 2422478 1039 1046 ChemicalEntity 5,7-DHT D015116
75 2422478 1057 1066 ChemicalEntity serotonin D012701
76 2422478 1164 1173 ChemicalEntity serotonin D012701
77 2422478 1252 1261 ChemicalEntity serotonin D012701
78 2422478 1262 1272 ChemicalEntity methyldopa D008750
79 2422478 1366 1376 ChemicalEntity methyldopa D008750
80 2422478 1385 1396 DiseaseOrPhenotypicFeature hypotension D007022
81 2422478 1437 1446 ChemicalEntity serotonin D012701
82 2422478 1489 1500 DiseaseOrPhenotypicFeature hypotensive D007022
83 2422478 1511 1521 ChemicalEntity methyldopa D008750
84 2491010 37 45 OrganismTaxon patients 9606
85 2491010 100 138 GeneOrGeneProduct Duchenne muscular dystrophy (DMD) gene 1756
86 2491010 174 201 DiseaseOrPhenotypicFeature Duchenne muscular dystrophy D020388
87 2491010 203 206 DiseaseOrPhenotypicFeature DMD D020388
88 2491010 210 235 DiseaseOrPhenotypicFeature Becker muscular dystrophy D020388
89 2491010 237 240 DiseaseOrPhenotypicFeature BMD D020388
90 2491010 312 315 GeneOrGeneProduct DMD 1756
91 2491010 558 566 OrganismTaxon patients 9606
92 2491010 592 602 GeneOrGeneProduct dystrophin 1756
93 2491010 809 817 OrganismTaxon patients 9606
94 2491010 908 916 OrganismTaxon patients 9606
95 2491010 953 956 DiseaseOrPhenotypicFeature DMD D020388
96 2491010 958 961 DiseaseOrPhenotypicFeature BMD D020388
97 2491010 1071 1074 DiseaseOrPhenotypicFeature BMD D020388
98 2491010 1075 1083 OrganismTaxon patients 9606
99 2491010 1105 1112 OrganismTaxon patient 9606
100 2491010 1186 1189 DiseaseOrPhenotypicFeature DMD D020388
101 2491010 1190 1198 OrganismTaxon patients 9606
102 2491010 1215 1223 OrganismTaxon patients 9606
103 2491010 1231 1234 DiseaseOrPhenotypicFeature BMD D020388
104 2491010 1235 1242 OrganismTaxon patient 9606
105 7468724 0 28 DiseaseOrPhenotypicFeature Cardiovascular complications D002318
106 7468724 45 56 ChemicalEntity terbutaline D013726
107 7468724 71 84 DiseaseOrPhenotypicFeature preterm labor D007752
108 7468724 93 121 DiseaseOrPhenotypicFeature cardiovascular complications D002318
109 7468724 147 155 OrganismTaxon patients 9606
110 7468724 169 180 ChemicalEntity terbutaline D013726
111 7468724 185 198 DiseaseOrPhenotypicFeature preterm labor D007752
112 7468724 211 225 ChemicalEntity corticosteroid D000305
113 7668252 11 16 OrganismTaxon human 9606
114 7668252 17 62 GeneOrGeneProduct very-long-chain acyl-coenzyme A dehydrogenase 37
115 7668252 119 127 OrganismTaxon patients 9606
116 7668252 220 225 OrganismTaxon human 9606
117 7668252 240 285 GeneOrGeneProduct very-long-chain acyl-coenzyme A dehydrogenase 37
118 7668252 287 292 GeneOrGeneProduct VLCAD 37
119 7668252 543 548 GeneOrGeneProduct VLCAD 37
120 7668252 603 618 DiseaseOrPhenotypicFeature VLCAD-deficient C536353
121 7668252 619 627 OrganismTaxon patients 9606
122 7668252 637 645 OrganismTaxon patients 9606
123 7668252 649 693 SequenceVariant 105-bp deletion encompassing bases 1078-1182 c|DEL|1078-1182|
124 7668252 697 702 GeneOrGeneProduct VLCAD 37
125 7668252 794 799 GeneOrGeneProduct VLCAD 37
126 7668252 864 880 DiseaseOrPhenotypicFeature VLCAD deficiency C536353
127 7668252 921 926 OrganismTaxon human 9606
128 7668252 927 932 GeneOrGeneProduct VLCAD 37
129 7668252 954 962 OrganismTaxon patients 9606
130 7668252 1033 1071 DiseaseOrPhenotypicFeature deficiency of the normal VLCAD protein C536353
131 7668252 1088 1109 ChemicalEntity long-chain fatty acid D005227
132 7668252 1141 1149 OrganismTaxon patients 9606
133 7668252 1166 1173 OrganismTaxon patient 9606
134 7668252 1195 1200 GeneOrGeneProduct VLCAD 37
135 7668252 1276 1289 ChemicalEntity palmitic acid D019308
136 7668252 1450 1466 DiseaseOrPhenotypicFeature VLCAD deficiency C536353
137 7905839 0 5 OrganismTaxon Human 9606
138 7905839 6 24 GeneOrGeneProduct mu opiate receptor 4988
139 7905839 112 117 OrganismTaxon human 9606
140 7905839 118 136 GeneOrGeneProduct mu opiate receptor 4988
141 7905839 225 228 OrganismTaxon rat 10116
142 7905839 229 247 GeneOrGeneProduct mu opiate receptor 25601
143 7905839 258 263 OrganismTaxon human 9606
144 7905839 264 282 GeneOrGeneProduct mu opiate receptor 4988
145 7905839 284 292 GeneOrGeneProduct h mu OR1 4988
146 7905839 334 337 OrganismTaxon rat 10116
147 7905839 362 368 GeneOrGeneProduct mu OR1 25601
148 7905839 387 393 ChemicalEntity opiate D053610
149 7905839 404 419 ChemicalEntity opioid peptides D018847
150 7905839 425 431 ChemicalEntity sodium D012964
151 7905839 437 440 ChemicalEntity GTP D006160
152 7905839 521 524 OrganismTaxon rat 10116
153 7905839 525 543 GeneOrGeneProduct mu opiate receptor 25601
154 7905839 556 566 ChemicalEntity cyclic AMP D000242
155 7905839 602 605 OrganismTaxon rat 10116
156 7905839 606 624 GeneOrGeneProduct mu opiate receptor 25601
157 7905839 670 678 GeneOrGeneProduct h mu OR1 4988
158 7905839 815 820 OrganismTaxon human 9606
159 7905839 1030 1056 DiseaseOrPhenotypicFeature neuropsychiatric disorders D001523
160 8755918 48 69 DiseaseOrPhenotypicFeature ataxia-telangiectasia D001260
161 8755918 107 128 DiseaseOrPhenotypicFeature ataxia-telangiectasia D001260
162 8755918 130 133 DiseaseOrPhenotypicFeature A-T D001260
163 8755918 160 163 GeneOrGeneProduct ATM 472
164 8755918 261 264 DiseaseOrPhenotypicFeature A-T D001260
165 8755918 361 377 SequenceVariant 137-bp insertion c|INS||137
166 8755918 476 479 DiseaseOrPhenotypicFeature A-T D001260
167 8755918 520 527 OrganismTaxon patient 9606
168 8755918 577 585 OrganismTaxon patients 9606
169 8755918 787 795 OrganismTaxon patients 9606
170 8755918 824 841 DiseaseOrPhenotypicFeature cerebellar ataxia D002524
171 8755918 1004 1007 DiseaseOrPhenotypicFeature A-T D001260
172 8755918 1008 1016 OrganismTaxon patients 9606
173 8755918 1095 1098 DiseaseOrPhenotypicFeature A-T D001260
174 8755918 1298 1301 GeneOrGeneProduct ATM 472
175 8829135 0 11 ChemicalEntity Nefiracetam C058876
176 8829135 13 20 ChemicalEntity DM-9384 C058876
177 8829135 31 42 ChemicalEntity apomorphine D001058
178 8829135 51 58 DiseaseOrPhenotypicFeature amnesia D000647
179 8829135 143 154 ChemicalEntity Nefiracetam C058876
180 8829135 166 177 ChemicalEntity pyrrolidone D011760
181 8829135 206 217 ChemicalEntity scopolamine D012601
182 8829135 226 275 DiseaseOrPhenotypicFeature learning and post-training consolidation deficits D007859
183 8829135 288 299 ChemicalEntity apomorphine D001058
184 8829135 437 448 ChemicalEntity nefiracetam C058876
185 8829135 462 469 DiseaseOrPhenotypicFeature amnesia D000647
186 8829135 481 501 ChemicalEntity dopaminergic agonism D018491
187 8829135 559 570 ChemicalEntity nefiracetam C058876
188 8829135 585 596 ChemicalEntity apomorphine D001058
189 8829135 738 749 ChemicalEntity nefiracetam C058876
190 8829135 754 765 ChemicalEntity apomorphine D001058
191 8829135 829 836 DiseaseOrPhenotypicFeature amnesic D000647
192 8829135 872 883 ChemicalEntity nefiracetam C058876
193 8829135 924 931 DiseaseOrPhenotypicFeature amnesia D000647
194 8829135 943 954 ChemicalEntity apomorphine D001058
195 8829135 1080 1091 ChemicalEntity nefiracetam C058876
196 8829135 1150 1152 ChemicalEntity 3H D014316
197 8829135 1153 1162 ChemicalEntity SCH 23390 C534628
198 8829135 1167 1169 ChemicalEntity 3H D014316
199 8829135 1170 1179 ChemicalEntity spiperone D013134
200 8829135 1193 1219 GeneOrGeneProduct D1 or D2 dopamine receptor 1812,1813
201 8829135 1265 1276 ChemicalEntity nefiracetam C058876
202 9294109 0 33 GeneOrGeneProduct Myotonic dystrophy protein kinase 13400
203 9294109 71 75 ChemicalEntity Ca2+ D002118
204 9294109 114 132 DiseaseOrPhenotypicFeature Myotonic dystrophy D009223
205 9294109 134 136 DiseaseOrPhenotypicFeature DM D009223
206 9294109 158 175 DiseaseOrPhenotypicFeature muscular disorder D009135
207 9294109 262 279 GeneOrGeneProduct DM protein kinase 13400
208 9294109 281 285 GeneOrGeneProduct DMPK 13400
209 9294109 398 402 GeneOrGeneProduct DMPK 13400
210 9294109 462 467 ChemicalEntity Ca2 + D002118
211 9294109 522 527 ChemicalEntity Ca2 + D002118
212 9294109 559 562 ChemicalEntity ATP D000255
213 9294109 631 635 GeneOrGeneProduct DMPK 13400
214 9294109 651 655 OrganismTaxon mice 10090
215 9294109 681 685 GeneOrGeneProduct DMPK 13400
216 9294109 727 732 ChemicalEntity Ca2 + D002118
217 9294109 830 835 ChemicalEntity Ca2 + D002118
218 9294109 840 844 ChemicalEntity Na + D012964
219 9294109 902 907 ChemicalEntity Ca2 + D002118
220 9294109 937 950 ChemicalEntity acetylcholine D000109
221 9294109 968 971 ChemicalEntity K + D011188
222 9294109 1009 1014 ChemicalEntity Ca2 + D002118
223 9294109 1075 1080 ChemicalEntity Ca2 + D002118
224 9294109 1100 1105 ChemicalEntity Ca2 + D002118
225 9294109 1155 1170 ChemicalEntity Na +/K + ATPase -
226 9294109 1175 1211 ChemicalEntity sarcoplasmic reticulum Ca2 + -ATPase D053498
227 9294109 1228 1232 GeneOrGeneProduct DMPK 13400
228 9294109 1279 1283 GeneOrGeneProduct DMPK 13400
229 9647766 66 71 OrganismTaxon human 9606
230 9647766 72 135 GeneOrGeneProduct nuclear encoded iron sulphur protein (IP) subunits of complex I 4720,4722,4726
231 9647766 141 146 OrganismTaxon human 9606
232 9647766 147 149 GeneOrGeneProduct IP 4720,4722,4726
233 9647766 173 215 GeneOrGeneProduct NADH:ubiquinone oxidoreductase (complex I) 4720,4722,4726
234 9647766 278 290 GeneOrGeneProduct flavoprotein -
235 9647766 292 294 GeneOrGeneProduct FP -
236 9647766 297 316 GeneOrGeneProduct iron-sulfur protein 4720,4722,4726
237 9647766 318 320 GeneOrGeneProduct IP 4720,4722,4726
238 9647766 327 346 GeneOrGeneProduct hydrophobic protein -
239 9647766 348 350 GeneOrGeneProduct HP -
240 9647766 369 371 GeneOrGeneProduct IP 4720,4722,4726
241 9647766 535 540 OrganismTaxon human 9606
242 9647766 541 580 GeneOrGeneProduct NADH:ubiquinone oxidoreductase subunits 4720,4722,4726
243 9647766 589 591 GeneOrGeneProduct IP 4720,4722,4726
244 9647766 606 612 GeneOrGeneProduct NDUFS2 4720
245 9647766 623 629 GeneOrGeneProduct NDUFS3 4722
246 9647766 644 650 GeneOrGeneProduct NDUFS6 4726
247 9647766 905 911 OrganismTaxon bovine 9913
248 9647766 1068 1073 OrganismTaxon human 9606
249 9647766 1113 1118 OrganismTaxon human 9606
250 9647766 1150 1155 OrganismTaxon human 9606
251 9647766 1189 1195 GeneOrGeneProduct NDUFS2 4720
252 9647766 1200 1206 GeneOrGeneProduct NDUFS3 4722
253 9647766 1274 1280 GeneOrGeneProduct NDUFS6 4726
254 9647766 1390 1396 GeneOrGeneProduct NDUFS2 4720
255 9647766 1425 1441 GeneOrGeneProduct protein kinase C 5578
256 9647766 1471 1477 GeneOrGeneProduct NDUFS3 4722
257 9647766 1514 1530 GeneOrGeneProduct casein kinase II 1457
258 9647766 1627 1656 DiseaseOrPhenotypicFeature enzymatic complex I-deficient C537475
259 9647766 1657 1665 OrganismTaxon patients 9606
260 9672936 0 9 ChemicalEntity Pethidine D008614
261 9672936 21 28 DiseaseOrPhenotypicFeature seizure D012640
262 9672936 63 72 ChemicalEntity pethidine D008614
263 9672936 77 95 DiseaseOrPhenotypicFeature postoperative pain D010149
264 9672936 172 181 ChemicalEntity pethidine D008614
265 9672936 188 195 OrganismTaxon patient 9606
266 9672936 246 264 DiseaseOrPhenotypicFeature postoperative pain D010149
267 9672936 339 346 DiseaseOrPhenotypicFeature seizure D012640
268 9672936 360 369 ChemicalEntity pethidine D008614
269 9672936 374 386 ChemicalEntity norpethidine C002752
270 9672936 522 530 DiseaseOrPhenotypicFeature toxicity D064420
271 9672936 592 601 ChemicalEntity pethidine D008614
272 9672936 652 661 ChemicalEntity pethidine D008614
273 9672936 666 678 ChemicalEntity norpethidine C002752
274 9672936 699 708 ChemicalEntity pethidine D008614
275 9672936 734 757 DiseaseOrPhenotypicFeature postoperative analgesia D010149
276 9746003 21 34 ChemicalEntity carbamazepine D002220
277 9746003 39 49 ChemicalEntity vigabatrin D020888
278 9746003 61 77 DiseaseOrPhenotypicFeature absence seizures D004832
279 9746003 79 92 ChemicalEntity Carbamazepine D002220
280 9746003 97 107 ChemicalEntity vigabatrin D020888
281 9746003 139 155 DiseaseOrPhenotypicFeature absence seizures D004832
282 9746003 271 284 ChemicalEntity carbamazepine D002220
283 9746003 324 334 ChemicalEntity Vigabatrin D020888
284 9746003 445 458 ChemicalEntity carbamazepine D002220
285 9746003 486 501 DiseaseOrPhenotypicFeature myoclonic jerks D009207
286 9746003 535 548 ChemicalEntity carbamazepine D002220
287 9746003 595 605 ChemicalEntity vigabatrin D020888
288 9746003 694 710 ChemicalEntity sodium valproate D014635
289 9746003 712 723 ChemicalEntity lamotrigine D000077213
290 9746003 728 740 ChemicalEntity ethosuximide D005013
291 10491763 0 27 GeneOrGeneProduct Hepatocyte nuclear factor-6 3175
292 10491763 74 90 DiseaseOrPhenotypicFeature type II diabetes D003924
293 10491763 140 147 GeneOrGeneProduct insulin 3630
294 10491763 184 217 GeneOrGeneProduct hepatocyte nuclear factor (HNF)-6 3175
295 10491763 292 315 DiseaseOrPhenotypicFeature maturity-onset diabetes D003924
296 10491763 389 394 GeneOrGeneProduct HNF-6 3175
297 10491763 430 479 DiseaseOrPhenotypicFeature Type II (non-insulin-dependent) diabetes mellitus D003924
298 10491763 497 504 GeneOrGeneProduct insulin 3630
299 10491763 518 525 ChemicalEntity glucose D005947
300 10491763 620 625 GeneOrGeneProduct HNF-6 3175
301 10491763 676 680 GeneOrGeneProduct MODY 3172,3651,6927
302 10491763 715 720 GeneOrGeneProduct MODY1 3172
303 10491763 722 727 GeneOrGeneProduct MODY3 6927
304 10491763 732 737 GeneOrGeneProduct MODY4 3651
305 10491763 754 762 OrganismTaxon patients 9606
306 10491763 779 795 DiseaseOrPhenotypicFeature Type II diabetes D003924
307 10491763 1070 1079 SequenceVariant Pro75 Ala rs74805019
308 10491763 1143 1151 SequenceVariant Pro75Ala rs74805019
309 10491763 1216 1224 OrganismTaxon patients 9606
310 10491763 1230 1255 DiseaseOrPhenotypicFeature Type II diabetes mellitus D003924
311 10491763 1304 1311 ChemicalEntity glucose D005947
312 10491763 1379 1386 ChemicalEntity glucose D005947
313 10491763 1413 1420 ChemicalEntity glucose D005947
314 10491763 1443 1459 DiseaseOrPhenotypicFeature Type II diabetic D003924
315 10491763 1460 1468 OrganismTaxon patients 9606
316 10491763 1573 1580 ChemicalEntity glucose D005947
317 10491763 1595 1602 GeneOrGeneProduct insulin 3630
318 10491763 1606 1615 GeneOrGeneProduct C-peptide 3630
319 10491763 1667 1672 GeneOrGeneProduct HNF-6 3175
320 10491763 1702 1718 DiseaseOrPhenotypicFeature Type II diabetes D003924
321 10491763 1738 1745 GeneOrGeneProduct insulin 3630
322 10491763 1759 1766 ChemicalEntity glucose D005947
323 10661407 0 8 GeneOrGeneProduct Langerin 50489
324 10661407 18 31 GeneOrGeneProduct C-type lectin 50489
325 10661407 156 185 GeneOrGeneProduct type II Ca2+-dependent lectin 50489
326 10661407 197 204 ChemicalEntity mannose D008358
327 10661407 284 292 GeneOrGeneProduct Langerin 50489
328 10661407 447 455 GeneOrGeneProduct Langerin 50489
329 10661407 514 522 GeneOrGeneProduct Langerin 50489
330 10661407 590 598 GeneOrGeneProduct Langerin 50489
331 10661407 699 707 GeneOrGeneProduct Langerin 50489
332 10661407 890 898 GeneOrGeneProduct Langerin 50489
333 10788334 25 30 GeneOrGeneProduct BRCA1 672
334 10788334 60 81 DiseaseOrPhenotypicFeature breast-ovarian cancer D061325
335 10788334 147 152 GeneOrGeneProduct BRCA1 672
336 10788334 157 162 GeneOrGeneProduct BRCA2 675
337 10788334 260 266 DiseaseOrPhenotypicFeature cancer D009369
338 10788334 321 345 DiseaseOrPhenotypicFeature breast or ovarian cancer D001943,D010051
339 10788334 358 364 DiseaseOrPhenotypicFeature cancer D009369
340 10788334 474 500 DiseaseOrPhenotypicFeature breast and ovarian cancers D001943,D010051
341 10788334 517 532 DiseaseOrPhenotypicFeature ovarian cancers D010051
342 10788334 559 573 DiseaseOrPhenotypicFeature breast cancers D001943
343 10788334 667 672 OrganismTaxon woman 9606
344 10788334 719 724 GeneOrGeneProduct BRCA1 672
345 10788334 729 734 GeneOrGeneProduct BRCA2 675
346 10788334 970 975 GeneOrGeneProduct BRCA1 672
347 10788334 982 1001 DiseaseOrPhenotypicFeature BRCA1 abnormalities OMIM:604370
348 10788334 1044 1058 DiseaseOrPhenotypicFeature ovarian cancer D010051
349 10788334 1097 1122 DiseaseOrPhenotypicFeature breast and ovarian cancer D001943,D010051
350 10788334 1155 1168 DiseaseOrPhenotypicFeature breast cancer D001943
351 10788334 1200 1205 GeneOrGeneProduct BRCA2 675
352 10788334 1223 1253 DiseaseOrPhenotypicFeature breast-ovarian cancer syndrome D061325
353 10788334 1448 1467 DiseaseOrPhenotypicFeature BRCA1 abnormalities OMIM:604370
354 10788334 1470 1478 SequenceVariant 5382insC c|INS|5382|C
355 10788334 1480 1484 SequenceVariant C61G rs28897672
356 10788334 1490 1498 SequenceVariant 4153delA c|DEL|4153|A
357 11009181 0 11 ChemicalEntity Apomorphine D001058
358 11009181 42 61 DiseaseOrPhenotypicFeature Parkinson's disease D010300
359 11009181 63 74 ChemicalEntity Apomorphine D001058
360 11009181 89 106 ChemicalEntity dopaminergic drug D004298
361 11009181 138 157 DiseaseOrPhenotypicFeature Parkinson's disease D010300
362 11009181 273 292 DiseaseOrPhenotypicFeature Parkinson's disease D010300
363 11009181 327 338 ChemicalEntity apomorphine D001058
364 11009181 493 504 ChemicalEntity apomorphine D001058
365 11009181 590 598 ChemicalEntity levodopa D007980
366 11009181 608 619 ChemicalEntity apomorphine D001058
367 11009181 678 686 OrganismTaxon patients 9606
368 11009181 745 756 ChemicalEntity apomorphine D001058
369 11009181 827 835 OrganismTaxon patients 9606
370 11009181 930 947 ChemicalEntity dopamine agonists D018491
371 11009181 951 966 ChemicalEntity COMT inhibitors D065098
372 11009181 1055 1066 ChemicalEntity apomorphine D001058
373 11009181 1174 1185 ChemicalEntity apomorphine D001058
374 11009181 1248 1256 ChemicalEntity levodopa D007980
375 11009181 1265 1276 DiseaseOrPhenotypicFeature dyskinesias D004409
376 11009181 1316 1327 ChemicalEntity apomorphine D001058
377 11009181 1407 1432 DiseaseOrPhenotypicFeature psychiatric complications D001523
378 11009181 1505 1516 ChemicalEntity apomorphine D001058
379 11009181 1542 1561 DiseaseOrPhenotypicFeature Parkinson's disease D010300
380 11054569 0 5 GeneOrGeneProduct Rab6c 84084
381 11054569 27 30 GeneOrGeneProduct rab 5870,84084
382 11054569 78 87 CellLine MCF7/AdrR 9606
383 11054569 101 105 GeneOrGeneProduct Rab6 5870
384 11054569 120 125 GeneOrGeneProduct Rab6c 84084
385 11054569 207 212 OrganismTaxon human 9606
386 11054569 239 252 DiseaseOrPhenotypicFeature breast cancer D001943
387 11054569 264 273 CellLine MCF7/AdrR 9606
388 11054569 361 366 GeneOrGeneProduct Rab6c 84084
389 11054569 402 411 CellLine MCF7/AdrR 9606
390 11054569 416 426 CellLine MES-SA/Dx5 9606
391 11054569 430 435 OrganismTaxon human 9606
392 11054569 440 455 DiseaseOrPhenotypicFeature uterine sarcoma D014594
393 11054569 516 525 CellLine MCF7/AdrR 9606
394 11054569 557 562 GeneOrGeneProduct Rab6c 84084
395 11054569 627 638 ChemicalEntity doxorubicin D004317
396 11054569 640 643 ChemicalEntity DOX D004317
397 11054569 646 651 ChemicalEntity taxol D017239
398 11054569 653 664 ChemicalEntity vinblastine D014747
399 11054569 670 681 ChemicalEntity vincristine D014750
400 11054569 821 824 ChemicalEntity DOX D004317
401 11054569 892 897 GeneOrGeneProduct Rab6c 84084
402 11054569 927 932 GeneOrGeneProduct Rab6c 84084
403 11054569 967 976 CellLine MCF7/AdrR 9606
404 11773892 0 23 DiseaseOrPhenotypicFeature End-stage renal disease D007676
405 11773892 25 29 DiseaseOrPhenotypicFeature ESRD D007676
406 11773892 83 94 GeneOrGeneProduct calcineurin 5530
407 11773892 167 178 GeneOrGeneProduct calcineurin 5530
408 11773892 190 202 ChemicalEntity cyclosporine D016572
409 11773892 207 217 ChemicalEntity tacrolimus D016559
410 11773892 239 250 DiseaseOrPhenotypicFeature nephrotoxic D007674
411 11773892 392 400 OrganismTaxon patients 9606
412 11773892 436 459 DiseaseOrPhenotypicFeature end-stage renal disease D007676
413 11773892 461 465 DiseaseOrPhenotypicFeature ESRD D007676
414 11773892 533 537 DiseaseOrPhenotypicFeature ESRD D007676
415 11773892 542 563 DiseaseOrPhenotypicFeature chronic renal failure D007676
416 11773892 565 568 DiseaseOrPhenotypicFeature CRF D007676
417 11773892 578 586 OrganismTaxon patients 9606
418 11773892 597 605 OrganismTaxon Patients 9606
419 11773892 797 805 OrganismTaxon Patients 9606
420 11773892 851 854 DiseaseOrPhenotypicFeature CRF D007676
421 11773892 858 862 DiseaseOrPhenotypicFeature ESRD D007676
422 11773892 871 874 DiseaseOrPhenotypicFeature CRF D007676
423 11773892 892 902 ChemicalEntity creatinine D003404
424 11773892 925 929 DiseaseOrPhenotypicFeature ESRD D007676
425 11773892 1051 1055 DiseaseOrPhenotypicFeature ESRD D007676
426 11773892 1092 1096 DiseaseOrPhenotypicFeature ESRD D007676
427 11773892 1155 1172 DiseaseOrPhenotypicFeature renal dysfunction D007674
428 11773892 1184 1187 DiseaseOrPhenotypicFeature CRF D007676
429 11773892 1197 1201 DiseaseOrPhenotypicFeature ESRD D007676
430 11773892 1231 1239 OrganismTaxon patients 9606
431 11773892 1241 1244 DiseaseOrPhenotypicFeature CRF D007676
432 11773892 1249 1253 DiseaseOrPhenotypicFeature ESRD D007676
433 11773892 1254 1262 OrganismTaxon patients 9606
434 11773892 1293 1303 ChemicalEntity creatinine D003404
435 11773892 1336 1344 OrganismTaxon patients 9606
436 11773892 1350 1370 DiseaseOrPhenotypicFeature hepatorenal syndrome D006530
437 11773892 1480 1490 ChemicalEntity creatinine D003404
438 11773892 1627 1637 ChemicalEntity creatinine D003404
439 11773892 1762 1765 DiseaseOrPhenotypicFeature CRF D007676
440 11773892 1769 1773 DiseaseOrPhenotypicFeature ESRD D007676
441 11773892 1948 1956 OrganismTaxon patients 9606
442 11773892 1965 1969 DiseaseOrPhenotypicFeature ESRD D007676
443 11773892 2027 2035 OrganismTaxon Patients 9606
444 11773892 2047 2051 DiseaseOrPhenotypicFeature ESRD D007676
445 11773892 2089 2093 DiseaseOrPhenotypicFeature ESRD D007676
446 11773892 2109 2117 OrganismTaxon patients 9606
447 11773892 2162 2170 OrganismTaxon patients 9606
448 11773892 2182 2186 DiseaseOrPhenotypicFeature ESRD D007676
449 11773892 2246 2254 OrganismTaxon Patients 9606
450 11773892 2297 2300 DiseaseOrPhenotypicFeature CRF D007676
451 11773892 2305 2309 DiseaseOrPhenotypicFeature ESRD D007676
452 11773892 2345 2349 DiseaseOrPhenotypicFeature ESRD D007676
453 11773892 2392 2400 OrganismTaxon patients 9606
454 11773892 2429 2437 OrganismTaxon Patients 9606
455 11773892 2450 2454 DiseaseOrPhenotypicFeature ESRD D007676
456 11773892 2499 2509 ChemicalEntity creatinine D003404
457 11773892 2538 2558 DiseaseOrPhenotypicFeature hepatorenal syndrome D006530
458 11773892 2590 2600 ChemicalEntity creatinine D003404
459 11773892 2675 2678 DiseaseOrPhenotypicFeature CRF D007676
460 11773892 2682 2686 DiseaseOrPhenotypicFeature ESRD D007676
461 12442272 0 4 SequenceVariant D90A rs80265967
462 12442272 5 9 GeneOrGeneProduct SOD1 6647
463 12442272 19 48 DiseaseOrPhenotypicFeature amyotrophic lateral sclerosis D000690
464 12442272 207 239 GeneOrGeneProduct copper/zinc superoxide dismutase 6647
465 12442272 241 245 GeneOrGeneProduct SOD1 6647
466 12442272 266 274 OrganismTaxon patients 9606
467 12442272 280 309 DiseaseOrPhenotypicFeature amyotrophic lateral sclerosis D000690
468 12442272 311 314 DiseaseOrPhenotypicFeature ALS D000690
469 12442272 325 350 DiseaseOrPhenotypicFeature neurodegenerative disease D019636
470 12442272 362 366 SequenceVariant D90A rs80265967
471 12442272 367 371 GeneOrGeneProduct SOD1 6647
472 12442272 585 589 SequenceVariant D90A rs80265967
473 12442272 590 594 GeneOrGeneProduct SOD1 6647
474 12442272 659 662 DiseaseOrPhenotypicFeature ALS D000690
475 12442272 777 780 DiseaseOrPhenotypicFeature ALS D000690
476 12442272 1041 1045 SequenceVariant D90A rs80265967
477 12442272 1346 1350 GeneOrGeneProduct SOD1 6647
478 12442272 1459 1463 SequenceVariant D90A rs80265967
479 12442272 1464 1468 GeneOrGeneProduct SOD1 6647
480 12442272 1511 1514 DiseaseOrPhenotypicFeature ALS D000690
481 14722929 17 25 DiseaseOrPhenotypicFeature deafness D003638
482 14722929 37 41 GeneOrGeneProduct GJB2 2706
483 14722929 80 84 GeneOrGeneProduct GJB2 2706
484 14722929 117 159 DiseaseOrPhenotypicFeature non-syndromic autosomal recessive deafness C567134
485 14722929 161 166 DiseaseOrPhenotypicFeature NSARD C567134
486 14722929 217 221 GeneOrGeneProduct GJB2 2706
487 14722929 251 255 GeneOrGeneProduct GJB2 2706
488 14722929 389 411 DiseaseOrPhenotypicFeature non-syndromic deafness D003638
489 14722929 538 542 GeneOrGeneProduct GJB2 2706
490 14722929 729 733 GeneOrGeneProduct GJB2 2706
491 14722929 749 760 SequenceVariant g.3318-6T>A g|SUB|T|3318-6|A
492 14722929 762 774 SequenceVariant g.3318-15C>T g|SUB|C|3318-15|T
493 14722929 776 788 SequenceVariant g.3318-34C>T g|SUB|C|3318-34|T
494 14722929 790 802 SequenceVariant g.3318-35T>G g|SUB|T|3318-35|G
495 14722929 829 843 SequenceVariant g.3455_3460del g|DEL|3455_3460|
496 14722929 845 867 SequenceVariant p.Asp46_Gln48delinsGlu p|INDEL|46_48|Glu
497 14722929 906 915 SequenceVariant g.3512C>A rs763572195
498 14722929 917 925 SequenceVariant p.Tyr65X rs763572195
499 14722929 950 959 SequenceVariant g.3395C>T g|SUB|C|3395|T
500 14722929 961 968 SequenceVariant p.Thr26 p|Allele|T|26
501 14722929 971 980 SequenceVariant g.3503C>T g|SUB|C|3503|T
502 14722929 982 989 SequenceVariant p.Asn62 p|Allele|N|62
503 14722929 992 1001 SequenceVariant g.3627A>C g|SUB|A|3627|C
504 14722929 1003 1011 SequenceVariant p.Arg104 p|Allele|R|104
505 14722929 1047 1056 SequenceVariant g.3816C>A rs111033360
506 14722929 1058 1069 SequenceVariant p.Val167Met rs111033360
507 14722929 1120 1130 SequenceVariant g.3352delG g|DEL|3352|G
508 14722929 1152 1158 SequenceVariant 30delG c|DEL|30|G
509 14722929 1162 1169 SequenceVariant 35 delG c|DEL|35|G
510 14722929 1172 1181 SequenceVariant g.3426G>A rs72474224
511 14722929 1183 1193 SequenceVariant p.Val37Ile rs72474224
512 14722929 1196 1205 SequenceVariant g.3697G>A rs111033196
513 14722929 1207 1218 SequenceVariant p.Arg127His rs111033196
514 14722929 1221 1230 SequenceVariant g.3774G>A rs111033186
515 14722929 1232 1243 SequenceVariant p.Val153Ile rs111033186
516 14722929 1250 1259 SequenceVariant g.3795G>A rs34988750
517 14722929 1261 1272 SequenceVariant p.Gly160Ser rs34988750
518 14722929 1313 1325 SequenceVariant g.3318-34C>T g|SUB|C|3318-34|T
519 14722929 1330 1340 SequenceVariant g.3352delG g|DEL|3352|G
520 14722929 1490 1495 DiseaseOrPhenotypicFeature NSARD C567134
521 14722929 1558 1566 DiseaseOrPhenotypicFeature deafness D003638
522 14722929 1611 1615 GeneOrGeneProduct GJB2 2706
523 14722929 1718 1726 DiseaseOrPhenotypicFeature deafness D003638
524 15000256 56 60 GeneOrGeneProduct FMR1 2332
525 15000256 69 77 DiseaseOrPhenotypicFeature autistic D001321
526 15000256 82 99 DiseaseOrPhenotypicFeature mentally retarded D008607
527 15000256 119 137 DiseaseOrPhenotypicFeature Fragile X syndrome D005600
528 15000256 174 192 DiseaseOrPhenotypicFeature mental retardation D008607
529 15000256 207 215 OrganismTaxon patients 9606
530 15000256 221 239 DiseaseOrPhenotypicFeature fragile X syndrome D005600
531 15000256 261 267 DiseaseOrPhenotypicFeature autism D001321
532 15000256 371 375 GeneOrGeneProduct FMR1 2332
533 15000256 407 415 OrganismTaxon patients 9606
534 15000256 500 504 GeneOrGeneProduct FMR1 2332
535 15000256 530 538 DiseaseOrPhenotypicFeature autistic D001321
536 15000256 542 559 DiseaseOrPhenotypicFeature mentally retarded D008607
537 15000256 699 707 OrganismTaxon patients 9606
538 15000256 729 736 OrganismTaxon patient 9606
539 15000256 802 839 SequenceVariant A to C substitution at nucleotide 879 rs782013865
540 15000256 1103 1107 GeneOrGeneProduct FMR1 2332
541 15000256 1131 1137 DiseaseOrPhenotypicFeature autism D001321
542 15000256 1142 1160 DiseaseOrPhenotypicFeature mental retardation D008607
543 15000256 1173 1181 OrganismTaxon patients 9606
544 15018851 25 40 OrganismTaxon cytomegalovirus 10358
545 15018851 55 62 OrganismTaxon patient 9606
546 15018851 68 76 DiseaseOrPhenotypicFeature lymphoma D008223
547 15018851 120 150 DiseaseOrPhenotypicFeature Long-term anti-cytomegalovirus D003586
548 15018851 152 155 DiseaseOrPhenotypicFeature CMV D003586
549 15018851 189 197 OrganismTaxon patients 9606
550 15018851 359 362 DiseaseOrPhenotypicFeature CMV D003586
551 15018851 424 427 DiseaseOrPhenotypicFeature CMV D003586
552 15018851 506 513 OrganismTaxon patient 9606
553 15018851 519 541 DiseaseOrPhenotypicFeature non-Hodgkin's lymphoma D008228
554 15018851 566 569 DiseaseOrPhenotypicFeature CMV D003586
555 15018851 650 653 DiseaseOrPhenotypicFeature CMV D003586
556 15018851 682 689 OrganismTaxon patient 9606
557 15018851 775 789 GeneOrGeneProduct glycoprotein B 2813
558 15018851 791 793 GeneOrGeneProduct gB 2813
559 15018851 853 856 DiseaseOrPhenotypicFeature CMV D003586
560 15018851 895 902 OrganismTaxon patient 9606
561 15018851 934 937 DiseaseOrPhenotypicFeature CMV D003586
562 15018851 999 1010 ChemicalEntity ganciclovir D015774
563 15018851 1012 1021 ChemicalEntity cidofovir D000077404
564 15018851 1026 1035 ChemicalEntity foscarnet D017245
565 15018851 1091 1110 GeneOrGeneProduct UL97 protein kinase 3077517
566 15018851 1149 1160 ChemicalEntity ganciclovir D015774
567 15018851 1261 1270 ChemicalEntity foscarnet D017245
568 15018851 1328 1333 SequenceVariant N495K p|SUB|N|495|K
569 15018851 1381 1392 ChemicalEntity ganciclovir D015774
570 15018851 1397 1406 ChemicalEntity cidofovir D000077404
571 15018851 1422 1427 SequenceVariant L501I p|SUB|L|501|I
572 15018851 1459 1462 DiseaseOrPhenotypicFeature CMV D003586
573 15018851 1490 1497 OrganismTaxon patient 9606
574 15033202 0 26 DiseaseOrPhenotypicFeature Nijmegen breakage syndrome D049932
575 15033202 69 89 DiseaseOrPhenotypicFeature primary microcephaly D008831
576 15033202 95 121 DiseaseOrPhenotypicFeature Nijmegen breakage syndrome D049932
577 15033202 132 184 DiseaseOrPhenotypicFeature autosomal recessive chromosomal instability disorder D043171
578 15033202 208 226 DiseaseOrPhenotypicFeature growth retardation D006130
579 15033202 228 251 DiseaseOrPhenotypicFeature congenital microcephaly D008831
580 15033202 253 269 DiseaseOrPhenotypicFeature immunodeficiency D007153
581 15033202 325 353 DiseaseOrPhenotypicFeature lymphoreticular malignancies D049932
582 15033202 360 386 DiseaseOrPhenotypicFeature Nijmegen breakage syndrome D049932
583 15033202 387 395 OrganismTaxon patients 9606
584 15033202 476 497 SequenceVariant 5 nucleotide deletion c|DEL||5
585 15033202 505 509 GeneOrGeneProduct NBS1 4683
586 15033202 516 528 DiseaseOrPhenotypicFeature Microcephaly D008831
587 15033202 552 578 DiseaseOrPhenotypicFeature Nijmegen breakage syndrome D049932
588 15033202 579 587 OrganismTaxon patients 9606
589 15033202 656 682 DiseaseOrPhenotypicFeature Nijmegen breakage syndrome D049932
590 15033202 703 723 DiseaseOrPhenotypicFeature primary microcephaly D008831
591 15033202 854 862 OrganismTaxon patients 9606
592 15033202 958 962 GeneOrGeneProduct NBS1 4683
593 15033202 979 1005 DiseaseOrPhenotypicFeature Nijmegen breakage syndrome D049932
594 15033202 1101 1127 DiseaseOrPhenotypicFeature Nijmegen breakage syndrome D049932
595 15033202 1128 1136 OrganismTaxon patients 9606
596 15033202 1353 1379 DiseaseOrPhenotypicFeature Nijmegen breakage syndrome D049932
597 15033202 1394 1420 DiseaseOrPhenotypicFeature Nijmegen breakage syndrome D049932
598 15033202 1575 1601 DiseaseOrPhenotypicFeature Nijmegen breakage syndrome D049932
599 15033202 1748 1774 DiseaseOrPhenotypicFeature Nijmegen breakage syndrome D049932
600 15033202 1775 1783 OrganismTaxon patients 9606
601 15033202 1925 1951 DiseaseOrPhenotypicFeature Nijmegen breakage syndrome D049932
602 15033202 1952 1960 OrganismTaxon patients 9606
603 15042318 0 19 DiseaseOrPhenotypicFeature Atrial fibrillation D001281
604 15042318 79 95 DiseaseOrPhenotypicFeature gastric lymphoma C535648
605 15042318 101 108 OrganismTaxon patient 9606
606 15042318 114 132 DiseaseOrPhenotypicFeature myotonic dystrophy D009223
607 15042318 134 152 DiseaseOrPhenotypicFeature Steinert's disease D009223
608 15042318 223 239 DiseaseOrPhenotypicFeature gastric lymphoma C535648
609 15042318 244 262 DiseaseOrPhenotypicFeature myotonic dystrophy D009223
610 15042318 294 312 DiseaseOrPhenotypicFeature muscular dystrophy D009136
611 15042318 325 344 DiseaseOrPhenotypicFeature atrial fibrillation D001281
612 15042318 368 379 ChemicalEntity doxorubicin D004317
613 15042318 411 418 OrganismTaxon patient 9606
614 15042318 420 439 DiseaseOrPhenotypicFeature Atrial fibrillation D001281
615 15042318 449 468 DiseaseOrPhenotypicFeature cardiac arrhythmias D001145
616 15042318 498 506 OrganismTaxon patients 9606
617 15042318 538 554 DiseaseOrPhenotypicFeature cardiac toxicity D066126
618 15042318 668 678 DiseaseOrPhenotypicFeature arrhythmia D001145
619 15042318 717 724 OrganismTaxon patient 9606
620 15064320 39 45 GeneOrGeneProduct SRD5A2 6716
621 15064320 63 87 DiseaseOrPhenotypicFeature male pseudohermaphrodite D058490
622 15064320 88 95 OrganismTaxon patient 9606
623 15064320 153 177 GeneOrGeneProduct 5-alpha-reductase type 2 6716
624 15064320 184 190 GeneOrGeneProduct SRD5A2 6716
625 15064320 206 230 DiseaseOrPhenotypicFeature male pseudohermaphrodite D058490
626 15064320 232 235 DiseaseOrPhenotypicFeature MPH D058490
627 15064320 237 244 OrganismTaxon patient 9606
628 15064320 257 269 ChemicalEntity testosterone D013739
629 15064320 271 272 ChemicalEntity T D013739
630 15064320 296 313 GeneOrGeneProduct androgen receptor 367
631 15064320 315 317 GeneOrGeneProduct AR 367
632 15064320 344 351 OrganismTaxon patient 9606
633 15064320 439 440 ChemicalEntity T D013739
634 15064320 457 485 ChemicalEntity human chorionic gonadotropin D006063
635 15064320 487 490 ChemicalEntity hCG D006063
636 15064320 559 561 GeneOrGeneProduct AR 367
637 15064320 588 594 GeneOrGeneProduct SRD5A2 6716
638 15064320 642 644 GeneOrGeneProduct AR 367
639 15064320 680 686 GeneOrGeneProduct SRD5A2 6716
640 15064320 786 860 SequenceVariant T nucleotide deletion, which predicts a frameshift mutation from codon 219 c|DEL|CODON219|T
641 15064320 929 959 SequenceVariant guanine (CGA) by adenine (CAA) rs9332964
642 15064320 971 1004 SequenceVariant glutamine replacement of arginine rs9332964
643 15064320 1006 1011 SequenceVariant R227Q rs9332964
644 15064320 1091 1098 OrganismTaxon patient 9606
645 15064320 1131 1137 GeneOrGeneProduct SRD5A2 6716
646 15064320 1185 1192 OrganismTaxon patient 9606
647 15064320 1203 1208 SequenceVariant R227Q rs9332964
648 15064320 1269 1272 DiseaseOrPhenotypicFeature MPH D058490
649 15064320 1273 1281 OrganismTaxon patients 9606
650 15064320 1323 1330 SequenceVariant Tdel219 c|DEL|CODON219|T
651 15064320 1389 1406 GeneOrGeneProduct 5-alpha-reductase 6716
652 15069170 28 36 ChemicalEntity thiazide D049971
653 15069170 47 67 GeneOrGeneProduct Na-Cl co-transporter 6559
654 15069170 85 93 OrganismTaxon patients 9606
655 15069170 99 118 DiseaseOrPhenotypicFeature Gitelman's syndrome D053579
656 15069170 132 151 DiseaseOrPhenotypicFeature Gitelman's syndrome D053579
657 15069170 153 155 DiseaseOrPhenotypicFeature GS D053579
658 15069170 163 191 DiseaseOrPhenotypicFeature autosomal recessive disorder D030342
659 15069170 237 245 ChemicalEntity thiazide D049971
660 15069170 256 276 GeneOrGeneProduct Na-Cl co-transporter 6559
661 15069170 278 282 GeneOrGeneProduct NCCT 6559
662 15069170 463 467 GeneOrGeneProduct NCCT 6559
663 15069170 491 499 OrganismTaxon patients 9606
664 15069170 505 507 DiseaseOrPhenotypicFeature GS D053579
665 15069170 572 580 OrganismTaxon patients 9606
666 15069170 586 588 DiseaseOrPhenotypicFeature GS D053579
667 15069170 668 672 GeneOrGeneProduct NCCT 6559
668 15069170 790 798 OrganismTaxon patients 9606
669 15069170 930 938 SequenceVariant c.185C>T rs371443644
670 15069170 940 948 SequenceVariant Thr60Met rs371443644
671 15069170 951 960 SequenceVariant c.1712C>T rs79351185
672 15069170 962 971 SequenceVariant Ala569Val rs79351185
673 15069170 974 983 SequenceVariant c.1930C>T rs200697179
674 15069170 985 994 SequenceVariant Arg642Cys rs200697179
675 15069170 997 1006 SequenceVariant c.2552T>A rs185927948
676 15069170 1008 1017 SequenceVariant Leu849His rs185927948
677 15069170 1023 1033 SequenceVariant c.1932delC c|DEL|1932|C
678 15069170 1066 1074 OrganismTaxon patients 9606
679 15069170 1087 1089 DiseaseOrPhenotypicFeature GS D053579
680 15069170 1090 1098 OrganismTaxon patients 9606
681 15069170 1155 1161 SequenceVariant c.7A>T c|SUB|A|7|T
682 15069170 1163 1170 SequenceVariant Met1Leu p|SUB|M|1|L
683 15069170 1173 1192 SequenceVariant c.1181_1186+20del26 c|DEL|1181_1186+20|26
684 15069170 1194 1210 SequenceVariant c.1811_1812delAT c|DEL|1811_1812|AT
685 15069170 1215 1225 SequenceVariant IVS16+1G>A c|SUB|G|IVS16+1|A
686 15069170 1262 1269 OrganismTaxon patient 9606
687 15069170 1275 1294 SequenceVariant c.1181_1186+20del26 c|DEL|1181_1186+20|26
688 15069170 1394 1402 OrganismTaxon patients 9606
689 15069170 1408 1418 SequenceVariant IVS16+1G>A c|SUB|G|IVS16+1|A
690 15069170 1434 1449 SequenceVariant 96 bp insertion c|INS||96
691 15069170 1505 1513 OrganismTaxon patients 9606
692 15069170 1655 1659 GeneOrGeneProduct NCCT 6559
693 15069170 1683 1691 OrganismTaxon patients 9606
694 15069170 1697 1699 DiseaseOrPhenotypicFeature GS D053579
695 15069170 1772 1776 GeneOrGeneProduct NCCT 6559
696 15069170 1794 1796 DiseaseOrPhenotypicFeature GS D053579
697 15069170 1797 1805 OrganismTaxon patients 9606
698 15086325 24 26 GeneOrGeneProduct F5 2153
699 15086325 58 99 DiseaseOrPhenotypicFeature inherited coagulation factor V deficiency D005166
700 15086325 193 227 DiseaseOrPhenotypicFeature inherited factor V (FV) deficiency D005166
701 15086325 314 349 DiseaseOrPhenotypicFeature inherited coagulation FV deficiency D005166
702 15086325 387 389 GeneOrGeneProduct FV 2153
703 15086325 456 458 GeneOrGeneProduct F5 2153
704 15086325 712 722 SequenceVariant IVS8 -2A>G c|SUB|A|IVS8-2|G
705 15086325 745 747 GeneOrGeneProduct F5 2153
706 15086325 952 1001 SequenceVariant insertion introduced eight additional amino acids p|INS||8
707 15086325 1016 1018 GeneOrGeneProduct FV 2153
708 15086325 1058 1060 GeneOrGeneProduct F5 2153
709 15086325 1100 1112 SequenceVariant 2238-9del AG c|DEL|2238_2239|AG
710 15086325 1167 1173 SequenceVariant 689 AA c|Allele|A|689
711 15086325 1198 1208 SequenceVariant G6410 by T g|SUB|G|6410|T
712 15086325 1250 1260 SequenceVariant Gly2079Val p|SUB|G|2079|V
713 15086325 1268 1270 GeneOrGeneProduct F5 2153
714 15086325 1287 1297 SequenceVariant IVS8 -2A>G c|SUB|A|IVS8-2|G
715 15086325 1299 1311 SequenceVariant 2238-9del AG c|DEL|2238_2239|AG
716 15086325 1316 1322 SequenceVariant G6410T g|SUB|G|6410|T
717 15086325 1374 1398 DiseaseOrPhenotypicFeature congenital FV deficiency D005166
718 15111599 0 9 GeneOrGeneProduct CRYBA3/A1 1411
719 15111599 55 101 DiseaseOrPhenotypicFeature autosomal dominant congenital nuclear cataract C565137
720 15111599 147 161 DiseaseOrPhenotypicFeature genetic defect D030342
721 15111599 177 204 DiseaseOrPhenotypicFeature congenital nuclear cataract C565137
722 15111599 447 455 DiseaseOrPhenotypicFeature cataract D002386
723 15111599 749 787 DiseaseOrPhenotypicFeature congenital nuclear lactescent cataract C565137
724 15111599 917 926 GeneOrGeneProduct CRYBA3/A1 1411
725 15111599 977 990 SequenceVariant 3-bp deletion c|DEL||3
726 15111599 1002 1011 SequenceVariant 279delGAG c|DEL|279|GAG
727 15111599 1039 1061 SequenceVariant deletion of glycine-91 p|DEL|91|G
728 15111599 1311 1319 SequenceVariant DeltaG91 p|DEL|91|G
729 15111599 1332 1341 GeneOrGeneProduct CRYBA3/A1 1411
730 15111599 1364 1421 DiseaseOrPhenotypicFeature autosomal dominant congenital nuclear lactescent cataract C565137
731 15111599 1442 1451 SequenceVariant IVS3+1G/A c|SUB|G|IVS3+1|A
732 15111599 1489 1505 DiseaseOrPhenotypicFeature zonular cataract C535342
733 15122711 0 4 GeneOrGeneProduct POLG 5428
734 15122711 31 47 DiseaseOrPhenotypicFeature Alpers' syndrome D002549
735 15122711 52 79 DiseaseOrPhenotypicFeature mitochondrial DNA depletion D028361
736 15122711 81 97 DiseaseOrPhenotypicFeature Alpers' syndrome D002549
737 15122711 109 130 DiseaseOrPhenotypicFeature neurogenetic disorder D009422
738 15122711 215 242 DiseaseOrPhenotypicFeature mitochondrial DNA depletion D028361
739 15122711 297 317 GeneOrGeneProduct DNA polymerase gamma 5428
740 15122711 319 323 GeneOrGeneProduct POLG 5428
741 15122711 356 364 DiseaseOrPhenotypicFeature seizures D012640
742 15122711 366 383 DiseaseOrPhenotypicFeature neurodegeneration D019636
743 15122711 389 402 DiseaseOrPhenotypicFeature liver disease D008107
744 15122711 434 450 DiseaseOrPhenotypicFeature Alpers' syndrome D002549
745 15122711 531 535 GeneOrGeneProduct POLG 5428
746 15122711 556 566 SequenceVariant Glu873Stop rs121918047
747 15122711 689 695 SequenceVariant G1681A rs113994095
748 15122711 730 739 SequenceVariant Ala467Thr rs113994095
749 15122711 756 760 GeneOrGeneProduct POLG 5428
750 15130900 0 22 DiseaseOrPhenotypicFeature Urinary bladder cancer D001749
751 15130900 26 50 DiseaseOrPhenotypicFeature Wegener's granulomatosis D014890
752 15130900 74 90 ChemicalEntity cyclophosphamide D003520
753 15130900 142 156 DiseaseOrPhenotypicFeature bladder cancer D001749
754 15130900 178 194 ChemicalEntity cyclophosphamide D003520
755 15130900 199 207 OrganismTaxon patients 9606
756 15130900 213 237 DiseaseOrPhenotypicFeature Wegener's granulomatosis D014890
757 15130900 292 301 OrganismTaxon Inpatient 9606
758 15130900 328 336 OrganismTaxon patients 9606
759 15130900 342 366 DiseaseOrPhenotypicFeature Wegener's granulomatosis D014890
760 15130900 426 432 DiseaseOrPhenotypicFeature Cancer D009369
761 15130900 486 500 DiseaseOrPhenotypicFeature bladder cancer D001749
762 15130900 623 639 ChemicalEntity cyclophosphamide D003520
763 15130900 644 658 DiseaseOrPhenotypicFeature bladder cancer D001749
764 15130900 738 752 DiseaseOrPhenotypicFeature bladder cancer D001749
765 15130900 759 783 DiseaseOrPhenotypicFeature Wegener's granulomatosis D014890
766 15130900 829 843 DiseaseOrPhenotypicFeature bladder cancer D001749
767 15130900 872 896 DiseaseOrPhenotypicFeature Wegener's granulomatosis D014890
768 15130900 959 975 ChemicalEntity cyclophosphamide D003520
769 15130900 1066 1080 DiseaseOrPhenotypicFeature bladder cancer D001749
770 15130900 1117 1133 ChemicalEntity cyclophosphamide D003520
771 15130900 1325 1339 DiseaseOrPhenotypicFeature bladder cancer D001749
772 15130900 1394 1418 DiseaseOrPhenotypicFeature Wegener's granulomatosis D014890
773 15130900 1437 1451 DiseaseOrPhenotypicFeature bladder cancer D001749
774 15130900 1532 1556 DiseaseOrPhenotypicFeature Wegener's granulomatosis D014890
775 15130900 1628 1644 ChemicalEntity cyclophosphamide D003520
776 15130900 1661 1675 DiseaseOrPhenotypicFeature bladder cancer D001749
777 15130900 1784 1808 DiseaseOrPhenotypicFeature Wegener's granulomatosis D014890
778 15177686 34 38 GeneOrGeneProduct HIRA 7290
779 15177686 39 45 GeneOrGeneProduct Tuple1 7290
780 15177686 59 98 DiseaseOrPhenotypicFeature DiGeorge and Velocardiofacial syndromes D004062
781 15177686 100 139 DiseaseOrPhenotypicFeature DiGeorge and Velocardiofacial syndromes D004062
782 15177686 141 144 DiseaseOrPhenotypicFeature DGS D004062
783 15177686 145 149 DiseaseOrPhenotypicFeature VCFS D004062
784 15177686 204 258 DiseaseOrPhenotypicFeature cardiovascular, craniofacial, and thymic malformations D018376,D019465
785 15177686 608 611 DiseaseOrPhenotypicFeature DGS D004062
786 15177686 612 616 DiseaseOrPhenotypicFeature VCFS D004062
787 15177686 675 679 GeneOrGeneProduct HIRA 7290
788 15177686 680 686 GeneOrGeneProduct Tuple1 7290
789 15177686 724 727 DiseaseOrPhenotypicFeature DGS D004062
790 15177686 728 732 DiseaseOrPhenotypicFeature VCFS D004062
791 15177686 845 849 GeneOrGeneProduct HIRA 7290
792 15177686 850 856 GeneOrGeneProduct Tuple1 7290
793 15177686 1214 1217 DiseaseOrPhenotypicFeature DGS D004062
794 15177686 1218 1222 DiseaseOrPhenotypicFeature VCFS D004062
795 15184369 0 4 ChemicalEntity Ca2+ D002118
796 15184369 23 27 ChemicalEntity Ca2+ D002118
797 15184369 38 43 GeneOrGeneProduct TRPV6 55503
798 15184369 116 121 GeneOrGeneProduct TRPV6 55503
799 15184369 133 136 CellLine HEK 9606
800 15184369 169 175 ChemicalEntity Ca(2+) D002118
801 15184369 184 190 ChemicalEntity Ca(2+) D002118
802 15184369 250 256 ChemicalEntity fura-2 D016257
803 15184369 292 298 ChemicalEntity Ca(2+) D002118
804 15184369 399 405 ChemicalEntity Ca(2+) D002118
805 15184369 422 426 ChemicalEntity EGTA D004533
806 15184369 471 474 CellLine HEK 9606
807 15184369 502 507 OrganismTaxon human 9606
808 15184369 508 513 GeneOrGeneProduct TRPV6 55503
809 15184369 629 633 ChemicalEntity EGTA D004533
810 15184369 669 675 ChemicalEntity Ca(2+) D002118
811 15184369 773 778 GeneOrGeneProduct TRPV6 55503
812 15184369 817 823 ChemicalEntity Ca(2+) D002118
813 15184369 860 865 GeneOrGeneProduct TRPV6 55503
814 15184369 902 908 ChemicalEntity Ca(2+) D002118
815 15184369 972 977 GeneOrGeneProduct TRPV6 55503
816 15184369 1137 1141 ChemicalEntity EGTA D004533
817 15184369 1147 1152 GeneOrGeneProduct TRPV6 55503
818 15184369 1188 1194 ChemicalEntity Ca(2+) D002118
819 15184369 1310 1315 GeneOrGeneProduct TRPV6 55503
820 15184369 1351 1357 ChemicalEntity Ca(2+) D002118
821 15184369 1424 1429 GeneOrGeneProduct TRPV6 55503
822 15184369 1473 1478 OrganismTaxon human 9606
823 15184369 1479 1484 GeneOrGeneProduct TRPV6 55503
824 15184369 1500 1505 OrganismTaxon human 9606
825 15184369 1506 1511 GeneOrGeneProduct TRPV6 55503
826 15184369 1512 1524 SequenceVariant Delta695-725 p|DEL|695-725|
827 15184369 1574 1580 ChemicalEntity Ca(2+) D002118
828 15184369 1657 1662 OrganismTaxon human 9606
829 15184369 1663 1668 GeneOrGeneProduct TRPV6 55503
830 15184369 1669 1674 SequenceVariant D542A p|SUB|D|542|A
831 15184369 1797 1802 GeneOrGeneProduct TRPV6 55503
832 15184369 1870 1873 CellLine HEK 9606
833 15191352 15 41 DiseaseOrPhenotypicFeature thyroid hormone resistance D018382
834 15191352 47 54 OrganismTaxon patient 9606
835 15191352 94 105 GeneOrGeneProduct T3 receptor 7068
836 15191352 112 150 DiseaseOrPhenotypicFeature Resistance to thyroid hormone syndrome D018382
837 15191352 152 155 DiseaseOrPhenotypicFeature RTH D018382
838 15191352 227 235 OrganismTaxon Patients 9606
839 15191352 241 244 DiseaseOrPhenotypicFeature RTH D018382
840 15191352 323 337 DiseaseOrPhenotypicFeature thyrotoxicosis D013971
841 15191352 353 367 DiseaseOrPhenotypicFeature hypothyroidism D007037
842 15191352 436 465 GeneOrGeneProduct thyroid hormone receptor beta 7068
843 15191352 472 479 GeneOrGeneProduct TR-beta 7068
844 15191352 495 502 OrganismTaxon patient 9606
845 15191352 508 511 DiseaseOrPhenotypicFeature RTH D018382
846 15191352 563 570 GeneOrGeneProduct TR-beta 7068
847 15191352 612 617 SequenceVariant I280S p|SUB|I|280|S
848 15191352 619 628 SequenceVariant 1123T-->G g|SUB|T|1123|G
849 15191352 738 743 SequenceVariant I280S p|SUB|I|280|S
850 15191352 793 800 OrganismTaxon patient 9606
851 15191352 838 871 DiseaseOrPhenotypicFeature impaired intellectual development D008607
852 15191352 873 885 DiseaseOrPhenotypicFeature hyperkinetic D006948
853 15191352 897 908 DiseaseOrPhenotypicFeature tachycardia D013610
854 15191352 910 939 DiseaseOrPhenotypicFeature hearing and visual impairment D006311,D014786
855 15191352 995 1000 SequenceVariant I280S p|SUB|I|280|S
856 15191352 1050 1057 GeneOrGeneProduct TR-beta 7068
857 15198485 18 27 SequenceVariant Lys198Asn rs5370
858 15198485 32 40 SequenceVariant -134delA rs1800997
859 15198485 70 82 GeneOrGeneProduct endothelin-1 1906
860 15198485 89 101 GeneOrGeneProduct Endothelin-1 1906
861 15198485 103 107 GeneOrGeneProduct ET-1 1906
862 15198485 225 229 GeneOrGeneProduct ET-1 1906
863 15198485 236 240 GeneOrGeneProduct EDN1 1906
864 15198485 315 324 SequenceVariant Lys198Asn rs5370
865 15198485 386 396 DiseaseOrPhenotypicFeature overweight D050177
866 15198485 440 448 SequenceVariant -134delA rs1800997
867 15198485 542 551 SequenceVariant Lys198Asn rs5370
868 15198485 568 572 GeneOrGeneProduct ET-1 1906
869 15198485 665 669 GeneOrGeneProduct ET-1 1906
870 15198485 748 752 GeneOrGeneProduct ET-1 1906
871 15198485 811 815 GeneOrGeneProduct ET-1 1906
872 15198485 824 828 GeneOrGeneProduct ET-1 1906
873 15198485 910 914 GeneOrGeneProduct ET-1 1906
874 15198485 922 926 GeneOrGeneProduct ET-1 1906
875 15198485 939 973 SequenceVariant Asn-type and Lys-type transfectant rs5370
876 15198485 1022 1026 GeneOrGeneProduct ET-1 1906
877 15198485 1033 1045 DiseaseOrPhenotypicFeature hypertensive D006973
878 15198485 1046 1054 OrganismTaxon patients 9606
879 15198485 1094 1120 SequenceVariant Lys to Asn at position 198 rs5370
880 15198485 1154 1167 DiseaseOrPhenotypicFeature hypertensives D006973
881 15198485 1240 1244 GeneOrGeneProduct ET-1 1906
882 15198485 1358 1367 SequenceVariant Lys198Asn rs5370
883 15198485 1405 1409 GeneOrGeneProduct ET-1 1906
884 15198485 1418 1422 GeneOrGeneProduct ET-1 1906
885 15198485 1458 1462 GeneOrGeneProduct EDN1 1906
886 15198485 1503 1512 SequenceVariant Lys198Asn rs5370
887 15198485 1605 1609 GeneOrGeneProduct EDN1 1906
888 15198485 1610 1619 SequenceVariant Lys198Asn rs5370
889 15198485 1659 1666 DiseaseOrPhenotypicFeature obesity D009765
890 15200408 29 34 OrganismTaxon human 9606
891 15200408 35 44 GeneOrGeneProduct uroplakin 11045,7380
892 15200408 54 75 DiseaseOrPhenotypicFeature vesicoureteral reflux C564042
893 15200408 137 158 DiseaseOrPhenotypicFeature vesicoureteral reflux C564042
894 15200408 160 163 DiseaseOrPhenotypicFeature VUR C564042
895 15200408 170 189 DiseaseOrPhenotypicFeature hereditary disorder D030342
896 15200408 343 362 DiseaseOrPhenotypicFeature hereditary diseases D030342
897 15200408 379 390 DiseaseOrPhenotypicFeature nephropathy D007674
898 15200408 416 439 DiseaseOrPhenotypicFeature end-stage renal failure D007676
899 15200408 513 518 OrganismTaxon mouse 10090
900 15200408 519 537 GeneOrGeneProduct uroplakin (UP) III 22270
901 15200408 647 650 DiseaseOrPhenotypicFeature VUR C564042
902 15200408 655 669 DiseaseOrPhenotypicFeature hydronephrosis D006869
903 15200408 723 725 GeneOrGeneProduct UP 11045,7380
904 15200408 753 758 OrganismTaxon human 9606
905 15200408 759 762 DiseaseOrPhenotypicFeature VUR C564042
906 15200408 786 788 GeneOrGeneProduct UP 11045,7380
907 15200408 801 809 OrganismTaxon patients 9606
908 15200408 845 848 DiseaseOrPhenotypicFeature VUR C564042
909 15200408 1162 1165 DiseaseOrPhenotypicFeature VUR C564042
910 15200408 1214 1217 DiseaseOrPhenotypicFeature VUR C564042
911 15200408 1298 1301 DiseaseOrPhenotypicFeature VUR C564042
912 15200408 1302 1310 OrganismTaxon patients 9606
913 15200408 1425 1428 DiseaseOrPhenotypicFeature VUR C564042
914 15200408 1447 1452 GeneOrGeneProduct UP Ia 11045
915 15200408 1470 1476 SequenceVariant C to T rs373513519
916 15200408 1495 1502 SequenceVariant Ala7Val rs373513519
917 15200408 1523 1529 GeneOrGeneProduct UP III 7380
918 15200408 1542 1548 SequenceVariant C to G c|SUB|C||G
919 15200408 1566 1575 SequenceVariant Pro154Ala p|SUB|P|154|A
920 15200408 1616 1619 DiseaseOrPhenotypicFeature VUR C564042
921 15200408 1766 1772 GeneOrGeneProduct UP III 7380
922 15200408 1781 1784 DiseaseOrPhenotypicFeature VUR C564042
923 15200408 1982 1991 GeneOrGeneProduct uroplakin 11045,7380
924 15200408 2037 2040 DiseaseOrPhenotypicFeature VUR C564042
925 15200408 2044 2050 OrganismTaxon humans 9606
926 15200408 2219 2222 DiseaseOrPhenotypicFeature VUR C564042
927 15200408 2223 2231 OrganismTaxon patients 9606
928 15200408 2293 2299 GeneOrGeneProduct UP III 22270
929 15200408 2309 2313 OrganismTaxon mice 10090
930 15200408 2347 2350 DiseaseOrPhenotypicFeature VUR C564042
931 15200408 2368 2382 DiseaseOrPhenotypicFeature hydronephrosis D006869
932 15200408 2387 2401 DiseaseOrPhenotypicFeature neonatal death D066087
933 15200408 2437 2446 GeneOrGeneProduct uroplakin 11045,7380
934 15200408 2505 2511 OrganismTaxon humans 9606
935 15233872 27 48 ChemicalEntity tincture of Crataegus C007145
936 15233872 52 65 ChemicalEntity isoproterenol D007545
937 15233872 74 95 DiseaseOrPhenotypicFeature myocardial infarction D009203
938 15233872 99 103 OrganismTaxon rats 10116
939 15233872 105 126 ChemicalEntity Tincture of Crataegus C007145
940 15233872 128 131 ChemicalEntity TCR C007145
941 15233872 137 181 ChemicalEntity alcoholic extract of the berries of hawthorn C007145
942 15233872 183 202 ChemicalEntity Crataegus oxycantha C007145
943 15233872 316 319 ChemicalEntity TCR C007145
944 15233872 346 367 DiseaseOrPhenotypicFeature myocardial infarction D009203
945 15233872 371 375 OrganismTaxon rats 10116
946 15233872 393 396 ChemicalEntity TCR C007145
947 15233872 490 495 ChemicalEntity lipid D008055
948 15233872 552 565 ChemicalEntity isoproterenol D007545
949 15233872 574 578 OrganismTaxon rats 10116
950 15233872 635 638 ChemicalEntity TCR C007145
951 15233872 653 666 ChemicalEntity isoproterenol D007545
952 15233872 746 749 ChemicalEntity ADP D000244
953 15233872 761 767 ChemicalEntity oxygen D010100
954 15233872 807 810 ChemicalEntity TCR C007145
955 15233872 861 874 ChemicalEntity isoproterenol D007545
956 15233872 878 881 OrganismTaxon rat 10116
957 15233872 929 932 ChemicalEntity TCR C007145
958 15233872 983 996 ChemicalEntity isoproterenol D007545
959 15233872 1000 1003 OrganismTaxon rat 10116
960 15241482 0 13 GeneOrGeneProduct Paraoxonase 1 5444
961 15241482 65 78 GeneOrGeneProduct paraoxonase 1 5444
962 15241482 80 84 GeneOrGeneProduct PON1 5444
963 15241482 145 167 DiseaseOrPhenotypicFeature coronary heart disease D003327
964 15241482 169 172 DiseaseOrPhenotypicFeature CHD D003327
965 15241482 201 206 DiseaseOrPhenotypicFeature death D003643
966 15241482 255 260 SequenceVariant 55M/L p|SUB|M|55|L
967 15241482 265 271 SequenceVariant 192Q/R p|SUB|Q|192|R
968 15241482 297 304 SequenceVariant -107C/T c|SUB|C|-107|T
969 15241482 369 372 DiseaseOrPhenotypicFeature CHD D003327
970 15241482 843 848 SequenceVariant 192RR p|Allele|R|192
971 15241482 1148 1153 OrganismTaxon women 9606
972 15241482 1183 1205 DiseaseOrPhenotypicFeature ischemic heart disease D017202
973 15241482 1236 1239 GeneOrGeneProduct PON 5444
974 15241482 1240 1246 SequenceVariant 192Q/R p|SUB|Q|192|R
975 15241482 1281 1284 DiseaseOrPhenotypicFeature CHD D003327
976 15241482 1326 1331 SequenceVariant 192RR p|Allele|R|192
977 15241482 1348 1353 OrganismTaxon women 9606
978 15241482 1407 1411 GeneOrGeneProduct PON1 5444
979 15241482 1412 1417 SequenceVariant 192RR p|Allele|R|192
980 15241482 1473 1478 OrganismTaxon women 9606
981 15241482 1563 1566 DiseaseOrPhenotypicFeature CHD D003327
982 15241482 1595 1598 DiseaseOrPhenotypicFeature CHD D003327
983 15241482 1644 1647 DiseaseOrPhenotypicFeature CHD D003327
984 15266215 15 31 GeneOrGeneProduct cyclooxygenase-2 5743
985 15266215 51 61 ChemicalEntity valdecoxib C406224
986 15266215 69 105 ChemicalEntity nonsteroidal antiinflammatory agents D000894
987 15266215 136 146 DiseaseOrPhenotypicFeature thrombotic D013927
988 15266215 157 165 OrganismTaxon patients 9606
989 15266215 171 180 DiseaseOrPhenotypicFeature arthritis D001168
990 15266215 239 249 DiseaseOrPhenotypicFeature thrombotic D013927
991 15266215 276 298 GeneOrGeneProduct cyclooxygenase (COX)-2 5743
992 15266215 337 372 ChemicalEntity nonsteroidal antiinflammatory drugs D000894
993 15266215 374 380 ChemicalEntity NSAIDs D000894
994 15266215 426 436 ChemicalEntity valdecoxib C406224
995 15266215 444 449 GeneOrGeneProduct COX-2 5743
996 15266215 491 499 OrganismTaxon patients 9606
997 15266215 505 519 DiseaseOrPhenotypicFeature osteoarthritis D010003
998 15266215 524 544 DiseaseOrPhenotypicFeature rheumatoid arthritis D001172